2025-06-14 04:26:23
Latest Post
ITC acquires shares of Sresta Natural Bioproducts Private Limited
Syngene International Ltd updates on USFDA inspection at Biocon Park, SEZ, Bengaluru
NTPC declares commercial operation of Unit 3 of North Karanpura Super Thermal Power Project
EPACK Durable Ltd awarded 'Best Overall Product' at Global LEAP Awards
IOL Chemicals and Pharmaceuticals Ltd registers Acetic Anhydride with REACH
Stock Report
Super Sales India Ltd Q4 FY2025 loss at Rs. 1.61 crore
Posted On : 2025-05-12 19:01:01( TIMEZONE : IST )
SUPER SALES INDIA LTD. has reported Standalone financial results for the period ended March 31, 2025.
Financial Results (Q4 FY2025) - QoQ Comparison
The company has reported total income of Rs. 107.2815 crores during the period ended March 31, 2025 as compared to Rs. 101.8664 crores during the period ended December 31, 2024.
The company has posted net profit / (loss) of Rs. -1.6191 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs. -2.5368 crores for the period ended December 31, 2024.
The company has reported EPS of Rs. -5.27 for the period ended March 31, 2025 as compared to Rs. -8.26 for the period ended December 31, 2024.
| Financials | Q4 FY2025 | Q3 FY2025 | % Change |
| Total Income | ₹ 107.2815 crs | ₹101.8664 crs |  5.32% |
| Net Profit | ₹-1.6191 crs | ₹-2.5368 crs |  36.18% |
| EPS | ₹-5.27 | ₹-8.26 | 36.20% |
Financial Results (Q4 FY2025) - YoY Comparison
The company has reported total income of Rs. 107.2815 crores during the period ended March 31, 2025 as compared to Rs.101.7356 crores during the period ended March 31, 2024.
The company has posted net profit / (loss) of Rs.-1.6191 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs.-1.9535 crores for the period ended March 31, 2024.
The company has reported EPS of Rs.-5.27 for the period ended March 31, 2025 as compared to Rs.-6.36 for the period ended March 31, 2024.
| Financials | Q4 FY2025 | Q4 FY2024 | % Change |
| Total Income | ₹ 107.2815 crs | ₹101.7356 crs | 5.45% |
| Net Profit | ₹-1.6191 crs | ₹-1.9535 crs | 17.12% |
| EPS | ₹-5.27 | ₹-6.36 | 17.14% |
Financial Results (Year Ended FY2025) - YoY Comparison
The company has reported total income of Rs.412.4462 crores during the Financial Year ended March 31, 2025 as compared to Rs.430.0088 crores during the Financial Year ended March 31, 2024.
The company has posted net profit / (loss) of Rs.-1.7588 crores for the Financial Year ended March 31, 2025 as against net profit / (loss) of Rs.19.8672 crores for the Financial Year ended March 31, 2024.
The company has reported EPS of Rs.-5.73 for the Financial Year ended March 31, 2025 as compared to Rs.64.68 for the Financial Year ended March 31, 2024.
| Financials | Year Ended FY2025 | Year Ended FY2024 | % Change |
| Total Income | ₹412.4462 crs | ₹430.0088 crs |  -4.08% |
| Net Profit | ₹-1.7588 crs | ₹19.8672 crs | -108.85% |
| EPS | ₹-5.73 | ₹64.68 | -108.86% |
Shares of SUPER SALES INDIA LTD. was last trading in BSE at Rs. 888.60 as compared to the previous close of Rs. 856.35. The total number of shares traded during the day was 523 in over 34 trades.
The stock hit an intraday high of Rs. 914.00 and intraday low of 875.10. The net turnover during the day was Rs. 461780.00.
